11.19 USD Market data. Sources for Share price
Close of Nov 6, 2026Market data as of Nov 6, 2026. Ratios computed no recompute on record.
ValueScreener company report
NASDAQ / Healthcare / Surgical & Medical Instruments & Apparatus
The evidence behind it
Overview
Market dataComputed
Four questions, at a glance
Quality
Return on invested capital, after tax
Why n/a
No figures have been computed for this company yet, though we hold its filings.
Valuation
Price to earnings
Why n/a
No figures have been computed for this company yet, though we hold its filings.
Cash generation
Free cash flow yield
Why n/a
No figures have been computed for this company yet, though we hold its filings.
Strength
Debt to equity
Why n/a
No figures have been computed for this company yet, though we hold its filings.
- Market capitalisation
372.5M USD Market data. Sources for Market capitalisation
Close of Nov 6, 2026- Newest accounts
- none on file
- Filed years
- n/a
The business, and the score behind its five axes
The reading, in brief
- Is it cheap
Price to earnings for Mobia Medical, Inc. Common Stock: n/a. We do not hold this figure for this company.
- Is it good
Return on invested capital for Mobia Medical, Inc. Common Stock: n/a. We do not hold this figure for this company.
- Is it safe
Interest coverage for Mobia Medical, Inc. Common Stock: n/a. We do not hold this figure for this company.
These are MOBI’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.
What changed
Company statement
No filing of this company is on file yet.
Quality
The returns the business earns on its capital, and the margins behind them.
Computed
| Figure | Value, source and document |
|---|---|
Return on invested capital, after taxWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Return on invested capital, after taxStatement not held |
Financial strength
What it owes against what it owns, and whether it can meet what falls due.
ComputedCompany statement
| Figure | Value, source and document |
|---|---|
Debt to equityWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Debt to equityStatement not held |
Current ratioWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Current ratioStatement not held |
Altman Z-scoreWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Altman Z-scoreClose of Nov 6, 2026 · Statement not held |
The balance sheet on file does not carry both total assets and total liabilities, so it is not drawn.
The balance sheet, line by line
Financial health
No annual balance sheet is on file for this company, so what it owns and what it owes cannot be shown.
Valuation context
Market dataComputed
| Figure | Value, source and document |
|---|---|
Price to earningsWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Price to earningsClose of Nov 6, 2026 · Statement not held |
P/E on trailing twelve monthsWhy n/aA trailing figure needs 4 filed quarters with the dates they were filed on, and we hold 2 for this company. Nothing is drawn rather than a line built from fewer. | n/a Computed. Sources for P/E on trailing twelve monthsClose of Nov 6, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings |
Price to bookWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Price to bookClose of Nov 6, 2026 · Statement not held |
Price to salesWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Price to salesClose of Nov 6, 2026 · Statement not held |
Enterprise value to EBITWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Enterprise value to EBITClose of Nov 6, 2026 · Statement not held |
Enterprise value to EBITDAWhy n/aNo enterprise value to EBITDA is held for this company. | n/a Computed. Sources for Enterprise value to EBITDAClose of Nov 6, 2026 · Statement not held |
Price to earnings over growthWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Price to earnings over growthClose of Nov 6, 2026 · Statement not held |
Graham numberWhy n/aNo Graham number: it needs positive filed earnings and book value per share. | n/a Computed. Sources for Graham numberStatement not held |
We publish no fair value or price target of our own. Value MOBI on your own assumptions in the DCF workbench, starting from the filed figures.
Its own record, and companies like it
Valuation
What the market charges for Mobia Medical, Inc. Common Stock today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.
| Share price | 11.19 USD |
|---|---|
| Market capitalisation | 372.5M USD |
| Enterprise value to EBITDA | n/a |
| Graham number | n/a |
| Diluted earnings per share | n/a |
Price to earnings on trailing twelve months: A trailing figure needs 4 filed quarters with the dates they were filed on, and we hold 2 for this company. Nothing is drawn rather than a line built from fewer.
Companies like Mobia Medical, Inc. Common Stock
- Avalo Therapeutics, Inc. (AVTX)Market cap 371.7M USD
- Rezolute, Inc. (RZLT)Market cap 375.3M USD
- Lyell Immunopharma, Inc. (LYEL)Market cap 364.1M USD
- AgomAb Therapeutics N.V. American Depositary Shares (AGMB)Market cap 376.0M USD
- Indaptus Therapeutics, Inc. (INDP)Market cap 376.0M USD
Same sector (Healthcare) and size band (Small, 300M to 2B), nearest in market value. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.
Cash generation
Computed
| Figure | Value, source and document |
|---|---|
Free cash flow yieldWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Free cash flow yieldClose of Nov 6, 2026 · Statement not held |
Dividend yieldWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Dividend yieldClose of Nov 6, 2026 · Statement not held |
Filings
Every figure, the year it is for and the document it was read from.
The figures on file
Computed from annual statements that name no SEC filing and, in a ratio with a price in it, the last close, dated on this page. So each figure below reads Market data, with the fiscal year it is for and the day it was supplied, and every blank carries the reason it is blank. Nothing here is a view on this company.
| Figure | Value | Year | As of |
|---|---|---|---|
| n/a | n/a | Nov 6, 2026 | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaShare price / earnings per share. Where the filing states no earnings per share this listing can be priced on, which is every 20-F and 40-F filer because theirs is stated per ordinary share, it is market capitalisation / net income: the same multiple, undiluted. As ofThe close on Nov 6, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
| n/a | n/a | Nov 6, 2026 | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaMarket capitalisation / shareholders equity As ofThe close on Nov 6, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
| n/a | n/a | Nov 6, 2026 | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
Formula(Market capitalisation + total debt - cash) / operating income, or over the filing's own EBIT (income before tax + interest expense) where the filer tags no operating line, as Johnson & Johnson does not in any of its ten filed years. As ofThe close on Nov 6, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
| n/a | n/a | Nov 6, 2026 | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaFree cash flow per share / share price x 100 As ofThe close on Nov 6, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
| n/a | n/a | n/a | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaVendor trailing-twelve-month return on invested capital where one is published, which uses after-tax operating profit over total assets less current liabilities. Otherwise our own recompute: NOPAT / (shareholders equity + total debt - cash) x 100, where NOPAT is the filed operating profit after tax, or the filing's own EBIT after tax where the filer tags no operating line. As ofThe filing date of the statements below. | |||
| n/a | n/a | Nov 6, 2026 | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaCommon dividends paid in the latest filed year / market capitalisation x 100. n/a where the filing cannot support it: a special or first-year payment, a total that mixes preferred dividends, or a cash-flow statement over 15 months old. As ofThe close on Nov 6, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
| n/a | n/a | n/a | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaTotal debt / shareholders equity As ofThe filing date of the statements below. | |||
| n/a | n/a | n/a | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaCurrent assets / current liabilities As ofThe filing date of the statements below. | |||
| n/a | n/a | Nov 6, 2026 | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaMarket capitalisation / revenue As ofThe close on Nov 6, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
| n/a | n/a | Nov 6, 2026 | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaPrice to earnings / the annual earnings growth rate, in percentage points As ofThe close on Nov 6, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
| n/a | n/a | Nov 6, 2026 | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
Formula1.2 x working capital/assets + 1.4 x retained earnings/assets + 3.3 x EBIT/assets + 0.6 x market value of equity/total liabilities + 1.0 x revenue/assets As ofThe close on Nov 6, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
| n/a | n/a | n/a | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaAn eight-variable index of year-on-year changes in receivables, gross margin, asset quality, revenue, depreciation, overheads, leverage and accruals As ofThe filing date of the statements below. | |||
| n/a | n/a | n/a | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaOne point each for: positive return on assets, positive operating cash flow, rising return on assets, operating cash flow above net income, falling leverage, rising current ratio, no new shares issued, rising gross margin, rising asset turnover. As ofThe filing date of the statements below. | |||
| 11.19 USD | n/a | Nov 6, 2026 | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
FormulaThe last close we hold, in the currency the listing trades in. As ofThe close on Nov 6, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
| n/a | n/a | Nov 6, 2026 | |
| n/a No figures have been computed for this company yet, though we hold its filings. | |||
Formula(price now - price a year ago) / price a year ago. It counts no dividend, so a high payer reads lower here than a holder's own return. As ofThe close on Nov 6, 2026, over the filed figures of n/a: a price is in this figure, and it moved after the filing. | |||
We hold no annual statement for this company, which is not the same as it having filed none. Prices as of Nov 6, 2026. No recompute is on record for it. Two facts, because a recompute is not a fresh quote.
The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.
Ten years of filed figures, year by year
Ten years of filed figures
No annual income statement is on file for this company, so there is no filed record of what it has earned.
Risks and guardrails
The accounting screens, the published tests, and the lines you can set to be told.
ComputedCompany statement
| Figure | Value, source and document |
|---|---|
Beneish M-scoreWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Beneish M-scoreStatement not held |
Piotroski F-scoreWhy n/aNo figures have been computed for this company yet, though we hold its filings. | n/a Computed. Sources for Piotroski F-scoreStatement not held |
The named tests
MOBI is an active listing and we hold no computed figures for it yet, so there is nothing to measure against a criterion.
Declared positions
Whether anybody here owns this company.
Positions declared by Javier Sanz Alvarez: no holding in any company shown here, as of October 3, 2026.
A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.
What this cannot tell you
- We hold no filed annual statement for this company yet, so the run above is shorter than a full decade and is counted as what it is.
And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.
Then we check your line against newly filed data and write to you the night our data shows it broke. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published. It is Professional, the plan a new account starts on for 30 days, one trial per person.
No card. 30 free days, and nothing is charged unless you choose a plan.
ValueScreener · valuescreener.ai · Computed from annual statements on file for this company that name no SEC filing, which are market data, and from dated closing prices. Every figure on this page opens into its formula and its inputs. A figure that cannot show that trail says so.
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.
Margin Notes
Once a week, what changed in the filings of US-listed companies, and what it can mean for a thesis.